KR101301548B1 - ７-〔（ｅ）-ｔ-부틸옥시미노메틸〕 캄토테신의 향상된경구 흡수를 위한 즉시­방출 치료 시스템 - Google Patents

７-〔（ｅ）-ｔ-부틸옥시미노메틸〕 캄토테신의 향상된경구 흡수를 위한 즉시­방출 치료 시스템 Download PDF

Info

Publication number
KR101301548B1
KR101301548B1 KR1020087003092A KR20087003092A KR101301548B1 KR 101301548 B1 KR101301548 B1 KR 101301548B1 KR 1020087003092 A KR1020087003092 A KR 1020087003092A KR 20087003092 A KR20087003092 A KR 20087003092A KR 101301548 B1 KR101301548 B1 KR 101301548B1
Authority
KR
South Korea
Prior art keywords
capsule
pharmaceutical composition
active ingredient
substrate
polyethylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020087003092A
Other languages
English (en)
Korean (ko)
Other versions
KR20080031945A (ko
Inventor
안토니오 롱고
실비아 파세
마시모 페드라니
Original Assignee
시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. filed Critical 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이.
Publication of KR20080031945A publication Critical patent/KR20080031945A/ko
Application granted granted Critical
Publication of KR101301548B1 publication Critical patent/KR101301548B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020087003092A 2005-08-04 2006-07-11 ７-〔（ｅ）-ｔ-부틸옥시미노메틸〕 캄토테신의 향상된경구 흡수를 위한 즉시­방출 치료 시스템 Expired - Fee Related KR101301548B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2005A000418 2005-08-04
IT000418A ITRM20050418A1 (it) 2005-08-04 2005-08-04 Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
PCT/EP2006/064111 WO2007017331A2 (en) 2005-08-04 2006-07-11 Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin

Publications (2)

Publication Number Publication Date
KR20080031945A KR20080031945A (ko) 2008-04-11
KR101301548B1 true KR101301548B1 (ko) 2013-09-06

Family

ID=37727667

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087003092A Expired - Fee Related KR101301548B1 (ko) 2005-08-04 2006-07-11 ７-〔（ｅ）-ｔ-부틸옥시미노메틸〕 캄토테신의 향상된경구 흡수를 위한 즉시­방출 치료 시스템

Country Status (19)

Country Link
US (1) US20090053307A1 (enExample)
EP (1) EP1915153B1 (enExample)
JP (1) JP5225084B2 (enExample)
KR (1) KR101301548B1 (enExample)
CN (1) CN101287466B (enExample)
AU (1) AU2006278114B2 (enExample)
BR (1) BRPI0614471A2 (enExample)
CA (1) CA2612080C (enExample)
CY (1) CY1114311T1 (enExample)
DK (1) DK1915153T3 (enExample)
ES (1) ES2407408T3 (enExample)
HR (1) HRP20130364T1 (enExample)
IT (1) ITRM20050418A1 (enExample)
MX (1) MX2008001029A (enExample)
PL (1) PL1915153T3 (enExample)
PT (1) PT1915153E (enExample)
RS (1) RS52777B (enExample)
SI (1) SI1915153T1 (enExample)
WO (1) WO2007017331A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011002688A (es) 2008-09-12 2011-04-12 Critical Pharmaceuticals Ltd Mejoramientos en la absorcion de agentes terapeuticos a traves de las membranas mucosas o la piel.
USD618617S1 (en) 2008-12-30 2010-06-29 Multiway Industries (Hk) Ltd. Three way electrical plug
US7892036B2 (en) * 2008-12-30 2011-02-22 Multiway Industries (Hk) Ltd. Electrical wall tap assembly
USD618175S1 (en) 2009-10-15 2010-06-22 Multiway Industries (Hk) Ltd. Three-outlet surge-protected adaptor
USD616823S1 (en) 2009-10-15 2010-06-01 Multiway Industries (Hk) Ltd. Single-outlet surge-protected adaptor
WO2011071194A1 (ko) * 2009-12-08 2011-06-16 주식회사 일화 20-O-β-D-글루코피라노실-20(S)-프로토파낙사디올을 포함하는 고체분산체
USD651977S1 (en) 2011-01-10 2012-01-10 Multiway Industries (Hk) Ltd. Multiple outlet electrical connector
CN108066311B (zh) * 2017-12-26 2020-09-08 兆科（广州）肿瘤药物有限公司 一种吉马替康胶囊及其制备方法
USD958079S1 (en) 2019-08-30 2022-07-19 Multiway Industries (Hk) Ltd. 3-way electrical tap
USD955993S1 (en) 2019-08-30 2022-06-28 Multiway Industries (Hk) Ltd. 3-way electrical tap
CN111529497A (zh) * 2020-02-11 2020-08-14 兆科（广州）肿瘤药物有限公司 一种吉马替康药物固体分散组合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006031A1 (en) * 1997-08-01 1999-02-11 Smithkline Beecham Corporation Pharmaceutical formulation for camptothecin analogues in gelatin capsule

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
SI0999826T1 (en) * 1997-07-29 2004-12-31 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DK1044977T3 (da) * 1999-03-09 2002-07-08 Sigma Tau Ind Farmaceuti Camptothecinderivater med antitumoraktivitet
KR20070058028A (ko) * 1999-05-24 2007-06-07 소너스파머슈티칼즈인코포레이티드 난용성 약물용 에멀젼 부형제
WO2005092302A2 (en) * 2004-03-26 2005-10-06 Novartis Ag Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
ES2395930T3 (es) * 2004-12-21 2013-02-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Procedimiento estereoselectivo y formas cristalinas de una camptotecina

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006031A1 (en) * 1997-08-01 1999-02-11 Smithkline Beecham Corporation Pharmaceutical formulation for camptothecin analogues in gelatin capsule

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cancer Research, vol.61, pp.7189-7195 (2001) *
Cancer Research, vol.61, pp.7189-7195 (2001)*

Also Published As

Publication number Publication date
KR20080031945A (ko) 2008-04-11
CN101287466B (zh) 2014-11-05
PT1915153E (pt) 2013-06-05
WO2007017331A2 (en) 2007-02-15
HRP20130364T1 (hr) 2013-05-31
AU2006278114A1 (en) 2007-02-15
SI1915153T1 (sl) 2013-06-28
AU2006278114B2 (en) 2011-06-23
BRPI0614471A2 (pt) 2011-03-29
MX2008001029A (es) 2008-03-14
HK1125293A1 (en) 2009-08-07
EP1915153B1 (en) 2013-04-10
ES2407408T3 (es) 2013-06-12
PL1915153T3 (pl) 2013-09-30
RS52777B (sr) 2013-10-31
JP2009503013A (ja) 2009-01-29
EP1915153A2 (en) 2008-04-30
CA2612080C (en) 2013-09-03
WO2007017331A3 (en) 2007-09-27
CN101287466A (zh) 2008-10-15
CY1114311T1 (el) 2016-08-31
ITRM20050418A1 (it) 2007-02-05
JP5225084B2 (ja) 2013-07-03
CA2612080A1 (en) 2007-02-15
US20090053307A1 (en) 2009-02-26
DK1915153T3 (da) 2013-06-24

Similar Documents

Publication Publication Date Title
ITRM960501A1 (it) Composizione farmaceutica a base di macrolide in dispersione solida
JP2013522353A (ja) ピリミジンオン誘導体を含む医薬組成物
JP6355645B2 (ja) 活性成分としてテトラゾール誘導体を含む、溶解性が改善された固体分散体
US20090181094A1 (en) Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents
US20100021538A1 (en) Pharmaceutical compositions containing heparin derivatives
JP2009544617A5 (enExample)
US10925871B2 (en) Pharmaceutical compositions of sitagliptin
KR20080031945A (ko) ７-〔（ｅ）-ｔ-부틸옥시미노메틸〕 캄토테신의 향상된경구 흡수를 위한 즉시­방출 치료 시스템
US20080286373A1 (en) Ziprasidone formulations
JPS5854122B2 (ja) 新規なエルゴットアルカロイド薬剤およびその製法
KR102490397B1 (ko) 두타스테라이드를 포함하는 고형 제제 및 이의 제조방법
KR102228135B1 (ko) 레스베라트롤을 포함하는 고형 제제 형태의 약학 조성물 및 레스베라트롤의 가용화 방법
KR102294171B1 (ko) 난용성 약물의 가용화제를 이용한 고체분산체 제조
WO2007091059A1 (en) Preparation and composition of a solid dosage form containing tacrolimus and/or sirolimus
HK1125293B (en) Immediate release therapeutic systems for improved oral absorption of 7-[(e)-tertbutyloxyiminoxmethyl] camptothecin
ZA200604757B (en) Pharmaceutical formulations of camptothecins and process for making same
JP2008518909A (ja) 非水性極性溶媒中の１０−ヒドロキシカンプトテシン化合物の溶解度を増加させるための薬剤製剤
CN108066311B (zh) 一种吉马替康胶囊及其制备方法
JP2003510269A (ja) バソプレシン拮抗薬製剤および方法
WO2017045603A1 (zh) 一种含喜树碱衍生物的注射制剂、其注射液、制备和应用
KR101799539B1 (ko) 도세탁셀을 포함하는 경구용 고형지질나노입자 조성물
KR101012903B1 (ko) 나노입자 형성을 이용하는 리세드로네이트 경질캡슐
TW201326181A (zh) 含有嘧啶酮衍生物的藥物組成物
KR20130028824A (ko) 타크로리무스를 포함하는 고체 분산체 및 이의 제조방법
HK1120437A (en) Pharmaceutical formulation with high stability and dissolution and manufacturing process

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

FPAY Annual fee payment

Payment date: 20160809

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20170810

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20180809

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20190808

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20200824

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20200824